NCT03085082 is a clinical trial of blood type test in Class II Malocclusion, sponsored by Cairo University.

Who is sponsoring NCT03085082?

NCT03085082 is sponsored by Cairo University.

What drugs are being tested in NCT03085082?

Interventions in NCT03085082: blood type test.

What condition does NCT03085082 study?

NCT03085082 studies Class II Malocclusion, Class III Malocclusion.

Is NCT03085082 still recruiting?

NCT03085082 is currently status unknown. Last updated 22 March 2017.

Last reviewed 2017-03-22 · How we verify

NCT03085082

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of the Relationship Between Blood Groups,RH and Skeletal Malocclusion : a Cross Sectional Study

Status unknown Last updated 22 March 2017

What this trial tests

trial testing blood type test in Class II Malocclusion in 300 participants. Status unknown.

Timeline

1 April 2017

Primary endpoint
1 September 2017

31 December 2017

Quick facts

Lead sponsor	Cairo University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 April 2017
Primary completion	1 September 2017
Estimated completion	31 December 2017

Drugs / interventions tested

blood type test

Conditions studied

Class II Malocclusion — all drugs for Class II Malocclusion →
Class III Malocclusion — all drugs for Class III Malocclusion →

Sponsor

Cairo University

Who can join

18 and older, any sex, with Class II Malocclusion or Class III Malocclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the study is searching if there is a relationship between the blood groups and RH and the skeletal malocclusion using the skeletal class I as a control group

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Class II Malocclusion

Currently open trials in the same condition.

NCT05684510 — Treatment of Mild Class II Malocclusion in Adult Patients With Clear Aligners Versus Fixed Multibracket Therapy · NA · recruiting
NCT07340242 — Dentoskeletal Effects of 3D-Printed Fixed Twin Block Versus MARA Appliances in Management of Skeletal Class II · NA · recruiting
NCT07361172 — Ready-made vs. Custom-made Carriere Motion Appliance · NA · recruiting
NCT06511219 — Maxillary Segmental Distalization Using Digitally Printed Appliances · NA · recruiting
NCT06651944 — Invisalign® System with Mandibular Advancement · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03085082 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 22 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03085082.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing